Data Insights
By Company Name
No Filter Selected
By Disease Name
No Filter Selected
By Drug Name
No Filter Selected
By Themes
No Filter Selected
Showing 1 results out of 1
Data Insights
VXS-1219 by Vaxxas for Influenza A Virus, H7N9 Subtype Infections: Likelihood of Approval
VXS-1219 is under clinical development by Vaxxas and currently in Phase I for Influenza A Virus, H7N9 Subtype Infections. According...